Allergy Immunotherapies Market Size, Share and Report 2027

IMARC Group’s latest research report, titled “Allergy Immunotherapies Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” the global allergy immunotherapies market report reached a value of US$ 2.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.63 Billion by 2027, exhibiting at a CAGR of 10.2% during 2022-2027. Allergy immunotherapy, also called desensitization or hypo-sensitization, represents a preventive medical treatment for allergic reactions to allergens, such as various foods, bee venom, grass pollens, drugs, house dust mites, etc. It involves altering the immune system response by gradually increasing the doses of the allergen after an analysis of the triggering factors for allergy symptoms, which typically requires skin and blood tests. Allergy immunotherapy aids in reducing inflammation, offering long-term results, changing the course of the disease, enhancing immunological tolerance, improving the quality of the life of the patients, etc.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/allergy-immunotherapies-market/requestsample

Perfect Solution For Increasing Revenue

May 27, 2022

How to Apply in university to study Abroad

May 27, 2022

Important Attribute and highlights of the Report:

Detailed analysis of the global market share
Market Segmentation by treatment type, allergy type and distribution channel.
Historical, current, and projected size of the market in terms of volume and value
Latest industry trends and developments
Competitive Landscape for allergy immunotherapies market
Strategies of major players and product offerings

The rising prevalence of allergies across the globe, on account of numerous environmental and lifestyle factors that, in turn, influence the functioning of the immune system, is primarily driving the allergy immonotherapies market. In addition to this, the elevating income levels of consumers and the growing healthcare expenditures are propelling the demand for sophisticated and long-term treatment options, which is further catalyzing the market growth. Moreover, the inflating investments in clinical research and development (R&D) activities by non-government and government bodies across countries are acting as significant growth-inducing factors. Furthermore, continuous developments in drug development technologies are enabling pharmaceutical firms to come up with more efficient immunotherapies for treating several allergies successfully, which is also augmenting the global market. Apart from this, the expanding allergy diagnostics sector is anticipated to fuel the allergy immonotherapies market over the forecasted period.

Key Players Included in Global Allergy Immunotherapies Market Research Report:

ALK-Abello A/S
Allergy Therapeutics
Stallergenes Greer
HAL Allergy Group
DBV Technologies
Merck Group
Aimmune Therapeutics
Circassia Pharmaceuticals
Anergis SA
Biomay AG etc.

COVID-19 Impact Overview:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global allergy immunotherapies market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on treatment type, allergy type and distribution channel.

Breakup by Treatment Type:

Subcutaneous Immunotherapy (SCIT)
Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

Allergic Rhinitis
Asthma
Food Allergy
Venom Allergy
Others

Breakup by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Breakup by Region:

Europe
North America
Asia Pacific
Middle East and Africa
Latin America

TOC for the Allergy Immunotherapies Market Research Report:

Preface
Scope and Methodology
Executive Summary
Introduction
Global Allergy Immunotherapies Market
SWOT Analysis
Value Chain Analysis
Price Analysis
Competitive Landscape

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.